To develop a wearable device that can detect epilepsy seizures. In particular, due to their prevalence, attention is focused on detecting the generalized tonic-clonic seizure (GTCS) type. When a seizure is detected, an alert phone call is initiated and an alarm SMS sent to the nearest health-care provider (and/or a predesignated family member), including the patient's location as global positioning system (GPS) coordinates. A wearable belt is developed including an Arduino processor that constantly acquires data from four different sensing modalities and monitors the acquired signal patterns for abnormalities. The sensors are a heart rate sensor, electromyography sensor, blood oxygen level (oxygen saturation) sensor, and an accelerometer to detect sudden falls. Higher-than-normal threshold levels are established for each sensor's signal. If two or more signal measurements exceed the corresponding threshold value for a predetermined time interval, then the seizure alarm is triggered. Clinical trials were not pursued in this study as this is the initial phase of system development (phase 0). Instead, the instrumented belt seizure detection prototype was tested on nine healthy individuals mimicking, to some degree, seizure symptoms. A total of eighteen trials took place of which half had <2 sensor thresholds exceeded and no alarm, whereas the other half resulted in activating the alarm when two or more sensor thresholds were exceeded for at least the predetermined time interval corresponding to each of the higher-than-normal sensor readings. For each trial that triggered the alarm when a seizure was detected, the on-board GPS and global system for mobile communication (GSM) units successfully initiated an alert phone call to a predesignated number in addition to sending an SMS message, including GPS location coordinates. Continuous real-time monitoring of signals from the four different sensors allows the developed wearable belt to detect GTCS while reducing false alarms. The proposed device produces an important alarm that may save a patient's life.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885511 | PMC |
http://dx.doi.org/10.4103/jmss.jmss_138_21 | DOI Listing |
Epilepsy Behav
January 2025
Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan; College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. Electronic address:
Purpose: Concurrent electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) have been used to assist in the presurgical localization of seizure foci in people with epilepsy. Our study aimed to examine the clinical feasibility of an optimized concurrent EEG-fMRI protocol.
Methods: The optimized protocol employed a fast-fMRI sequence (sampling rate = 10 Hz) with a spare arrangement, which allowed a time window of 1.
Sci Adv
January 2025
Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano and IU.NET, Piazza Leonardo da Vinci 32, 20133 Milano, Italy.
Neurological disorders are a substantial global health burden, affecting millions of people worldwide. A key challenge in developing effective treatments and preventive measures is the realization of low-power wearable systems with early detection capabilities. Traditional strategies rely on machine learning algorithms, but their computational demands often exceed what miniaturized systems can provide.
View Article and Find Full Text PDFBiomed Chromatogr
February 2025
Department of Clinical Pharmacology and Pharmacometrics, Longboard Pharmaceuticals, Inc. is a part of Lundbeck as a wholly owned subsidiary of Lundbeck LLC, La Jolla, California, USA.
Bexicaserin is a highly selective agonist at the 5-HT receptor in clinical development for the treatment of seizures associated with developmental and epileptic encephalopathies (DEEs). We report an LC-MS/MS method for the quantitative estimation of bexicaserin in human plasma and urine. The sample preparation involves the extraction of bexicaserin and internal standard (CD-bexicaserin; IS) from 150 μL plasma and 50 μL urine using a solid phase extraction method.
View Article and Find Full Text PDFActa Neurochir (Wien)
January 2025
Department of Neurosurgery, Maastricht University Medical Centre, Maastricht, Netherlands.
Purpose: In resective epilepsy surgery for drug-resistant focal epilepsy (DRE), good seizure outcome is strongly associated with visualization of an epileptogenic lesion on MRI. Standard clinical MRI (≤ 3 Tesla (T)) may fail to detect subtle lesions. 7T MRI enhances detection and delineation, the potential benefits of increasing field strength to 9.
View Article and Find Full Text PDFObstet Gynecol
January 2025
Riley Children's, the Division of Maternal-Fetal Medicine, Indiana University Health Fetal Center, and the Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana; the Division of Maternal-Fetal Medicine and Surgery, Fetal Care and Surgery Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; the Department of Obstetrics and Gynecology, Brown University Medical School, Providence, Rhode Island; the Fetal Medicine Unit, St George's Hospital, St George's University of London, London, United Kingdom; the Division of Maternal-Fetal Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania; and the Division of Maternal-Fetal Medicine, The Ohio State University, Columbus, Ohio.
Objective: To investigate short-term maternal and neonatal outcomes in individuals with twin pregnancies and two prior cesarean deliveries who underwent trial of labor after cesarean (TOLAC).
Methods: A cross-sectional study of live-birth data was conducted between 2014 and 2021 in the United States. Individuals with more than two prior cesarean deliveries and multiple gestations higher than twins were excluded.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!